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Limited Common Femoral Endarterectomy, &
Profundoplasty as an Effective Option in Limb Threatening
Ischaemia. A Minimalistic Approach in High-risk Patients
A. El-Bakr, W. Tawﬁck, M. Tubassam
Department of Vascular & Endovascular Surgery, University College Hospital,
Galway, Ireland
Objectives: The importance of the profunda femoris artery
(PFA) in maintaining adequate limb perfusion, on a back-
ground of occluded superﬁcial femoral artery (SFA) has
been previously documented. Femoro-popliteal TASC-D le-
sions requiring extensive revascularisations, could prove
challenging in frail patients. We aim to conﬁrm that ﬂow
restoration to the profunda is an adequate option in these
high-risk patients.
Methods: Critical limb ischaemia (CLI) patients with fem-
oro-popliteal TASC-D lesions, presenting with ASA grade-3
or higher were considered for limited CFA endarterectomy
with profundoplasty. No further revascularization was per-
formed for their infra-inguinal lesions. Patient de-
mographics, risk factors, lesion characteristics and
outcomes were recorded. Primary endpoint was limb
salvage. Secondary endpoints were technical success, clin-
ical and haemodynamic improvement, freedom from major
adverse clinical events (MACE) and mortality.
Results: From January till November 2014, eight patients
presented with CLI (5 with rest pain and 3 with tissue loss).
Mean age was 74.2 years (6.4). Five patients were ASA
grade-3. Three were grade-4. Limb salvage at 6 months was
87.5% (n ¼ 7). One patient developed a minor complication
(seroma) that was managed conservatively. Primary patency
at 6 months was 100%. ABI’s improved by 0.15 or more in
100% of patients. 87.5% (n ¼ 7) improved clinically to
Rutherford grade 3 or less. Freedom from MACE was 87.5%
and survival was 100% at 6 months.
Conclusion: Restoring limb perfusion through the profunda
only, is still very effective, & could be the safest option in a
selected group of patients. Longer follow-up is needed to
verify the need for more extensive revascularization, and
long-term outcomes.E-mail address: bridget.egan1@gmail.com
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E. Boyle, N. Lynch, M. Cunningham, S.Walsh, O. Abdulrahim, P. Grace,
P. Burke, E. Kavanagh
Department of Vascular Surgery, University Hospital Limerick, Ireland
Background: The short term advantages of endovascular
aneurysm repair (EVAR) over open repair are well estab-
lished but concerns remain regarding long term durability
and outcomes.
Methods: We examined long term outcomes and secondary
interventions in consecutive patients who underwent EVAR
in our centre between March 2006 and December 2014,
both elective and emergency. Revisions were performed at
University Hospital Limerick or St. James’s Hospital.
Reason for failure Intervention N
Type 1a endoleak Aortic cuff 6Explantation 4
Palmaz stent 1Type 1b endoleak Iliac limb extension 7
Bilateral iliac limb extension 1
Iliac branch device 1Type 2 endoleak Embolisation of lumbar artery 1
Ligation accessory renal artery 1Type 3 endoleak Iliac bridging stent 2
Aorto enteric ﬁstula Repair of ﬁstula 1
Iliac thrombus Iliac stent 1
Occluded limb Femefem crossover 4
Occluded graft Ax-bifem graft 1Results:
In total 186 primary EVARs were performed. Median age
was 76.5 years (range 57e93) and median aneurysm
diameter was 5.8cm (range 4.7e11cm). Overall, 38 deaths
were conﬁrmed on follow-up, elective in-hospital mortality
was 2.3% (4/175), in addition 12 elective patients died
within 2 years from various causes (6.9%). There were 6
primary technical failures of which 2 died and 31 late re-
interventions in 28 patients (15.1 %). The median time to
re-intervention was 49.6 months (range 0e84). In 8/29
cases (27.6%), the re-intervention was emergent. In the
revision group there was a single death (following explan-
tation) (3.4%) and an additional unﬁt patient declined
revision and subsequently died of presumed rupture.
Conclusions: EVAR revision surgery is complex and varied
but can be managed successfully. Post-operative surveil-
lance is vital to plan revision surgery in an elective setting.
When the Best isn’t Good Enough: Venous Thoracic Outlet
Syndrome Resistant to Standard Therapy
G. Handelman, A. Ryan, E. Quinn, M. McMonagle, K.S. Cross
Department of Vascular Surgery, University Hospital Waterford, Dunmore Road,
Waterford, Ireland
e20 Oral AbstractsA 34 year old physiotherapist developed right sided arm
pain, swelling and superﬁcial venous dilatation after per-
forming the butterﬂy stroke while training for a triathalon.
His medical history was signiﬁcant for a previous fracture of
his right clavicle requiring plate ﬁxation; a subsequent
break in the plate required repeat internal ﬁxation. CT
angiography revealed an occlusion of the right subclavian
vein at the location where a screw from his plate ﬁxation
was impinging on his thoracic outlet, consistent with
venous thoracic outlet syndrome (VTOS). Treatment
comprised of angiography and catheter directed throm-
bolysis followed by heparinisation and thoracic outlet
decompression via 1st rib and partial scalenus anterior
resection with removal of the clavicular plate. Post opera-
tively the patient recovered well and was discharged on
therapeutic low molecular weight heparin, with functional
improvement. However, follow up venography was per-
formed and unfortunately imaging showed complete
rethrombosis of the vein. He was discharged on continuing
therapeutic low molecular weight heparin while further
treatment options were considered.
This case demonstrates the management dilemma of a
young active man with a physical occupation who has failed
standard therapy for VTOS. Stenting is associated with poor
outcomes in this setting. Venous repair/bypass/patch or
temporary AV ﬁstula is sometimes advocated but usually
reserved for those with signiﬁcant haemodynamic effects. A
conservative approach with long term anticoagulation may
be the only reasonable tactic in this situation, with the
possibility of reimaging and venoplasty if the vein is
amenable to same at a future point in time.Major Lower Extremity Amputation: Trends and
Implications for Vascular Service Design
C. Fenelon, H.M. Mohan, J. Stow, P. Nicholson, A. Huang, N. Ryall,
S. Sheehan, D. Mehigan, M.C. Barry
Department of Vascular Surgery, St. Vincent’s University Hospital, Elm Park,
Dublin 4, Ireland
Background: Understanding trends and outcomes in major
lower extremity amputation for peripheral vascular disease
is crucial in planning rehabilitation and preventative ser-
vices. The aim of the present study was to examine out-
comes following major lower extremity amputation in a
tertiary vascular center and the impact on rehabilitation
services.
Methods: A retrospective review was conducted of all pa-
tients who underwent above or below knee amputation
from 2000e2007 at St. Vincent’s University Hospital. Base-
line demographic information, surgical data and preopera-
tive outcomes were assessed. Medium term functional
outcomes were assessed using data from the National
Rehabilitation Center, Dun Laoghaire. Statistical analysis was
performed using SPSS 18.0, with the Mann-Whitney U test
used to analysis continuous variables and Fischer’s exact
test for categorical variables.Results: In total, 194 major lower extremity amputations
were performed on 164 patients during the study period.
36% were female. The median age was signiﬁcantly higher
for those undergoing AKA than BKA (AKA median age 75
versus BKA 67 p ¼ 0.0007). Of those that survived to
hospital discharge, the median survival was 17 months, with
a range of 2e106 months. 51% survived less than 2 years
post-amputation. Interestingly, the median length of stay
was signiﬁcantly higher for BKA than AKA (40 days versus 26
days p ¼ 0.032), which may be due to waiting times for
rehabilitation services.
Conclusion: Major lower limb amputation has signiﬁcant
morbidity and mortality, and is associated with long inpa-
tient stays, with implications for planning both acute
vascular and rehabilitation services.
VTE Prophylaxis in Surgical Patients 2014/2015: A Tallaght
Perspective
S. Anderson, E. Nugent, S. Tierney, T.M. Feeley, B. Egan
Department of Vascular Surgery, The Adelaide and Meath Hospital, Tallaght,
Dublin 24, Ireland
Objective: Acute venous thromboembolism (VTE) remains a
signiﬁcant cause of morbidity and mortality in surgical pa-
tients despite the use of chemical and mechanical prophy-
laxis. As a result of this, Tallaght Hospital updated its VTE
prophylaxis guidelines for surgical patients in 2014. The aim
of this study was to compare current VTE prophylaxis
against these guidelines.
Methods: Data was collected from 53 surgical patients who
had been admitted for more than 24 hours, excluding or-
thopaedic patients, over two separate days.
Results: Of the 53 patients studied, mechanical VTE pro-
phylaxis was appropriately prescribed in 84.9% of cases
(n ¼ 45). However, only 41% of patients prescribed
Thromboembolic Deterrent Stockings (TEDS) were wearing
them at the time of the audit.
Chemical VTE prophylaxis was appropriately prescribed in
83% of patients (n¼ 44). Lack of dose adjustment for patient
weight was the main reason for inappropriate prescribing.
A higher compliance rate of VTE prophylaxis was seen in
elective vs emergency admission (76.9% vs 56%) and in
patients who underwent surgery vs those who had not
(83.3% vs 65.7%)
Overall, VTE prophylaxis was appropriately prescribed in
71.7% of patients (n ¼ 38). Despite this, only 41.5%
(n ¼ 22) received appropriate prophylaxis due to patients
not wearing TEDS.
Conclusion: Although VTE prophylaxis is appropriately pre-
scribed in the majority of cases, patient compliance with me-
chanical VTE prophylaxis needs to improve. In order to achieve
this, a patient information leaﬂet will be given to surgical pa-
tients on admission, and NCHDs have been encouraged to
prescribe TEDS separately on the drug Kardex to allow the
nursing staff to check and document patient compliance on a
daily basis. A re-audit will take place to assess the impact of
these changes on the rate of appropriate prophylaxis.
